Brigit Biofarmaka Teknologi Tbk. vs Trimuda Nuansa Citra Tbk. — how do they compare? Brigit Biofarmaka Teknologi Tbk. trades at Rp254 (market cap 172.82B, 592.2K 24h volume), while Trimuda Nuansa Citra Tbk. trades at Rp143 (market cap 59.03B, 495.2K 24h volume). The key difference: Brigit Biofarmaka Teknologi Tbk. is far larger — about 2.9× Trimuda Nuansa Citra Tbk.'s market cap, and Brigit Biofarmaka Teknologi Tbk. is more actively traded (592.2K versus 495.2K). Which is the better fit depends on your goals.
| OBAT | TNCA | |
|---|---|---|
Market Cap | 172.82B | 59.03B |
Volume | 592.2K | 495.2K |
Lot | 5.92K | 4.95K |
Turnover | 147.05M | 70.51M |
Average Price | 248.31 | 142.38 |
Value | 147.05M | 70.51M |
Indicative Equilibrium Price | 254 | 143 |
Indicative Equilibrium Volume | 10 | 9 |
Trailing returns across standard periods
Latest headlines on both assets
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →PT Trimuda Nuansa Citra Tbk(the Company) was established in Indonesia in accordance with Deed of Establishment of Limited Liability Company Company No. 21 dated May 4, 1995 made before H. Asmawel Amin, S.H., Notary in Jakarta.
Read more on TNCA →